|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hua F, Shang S and Hu ZW: Seeking new
anti-cancer agents from autophagy-regulating natural products. J
Asian Nat Prod Res. 19:305–313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nazir HF, AlFutaisi A, Zacharia M,
Elshinawy M, Mevada ST, Alrawas A, Khater D, Jaju D and Wali Y:
Vincristine-induced neuropathy in pediatric patients with acute
lymphoblastic leukemia in Oman: Frequent autonomic and more severe
cranial nerve involvement. Pediatr Blood Cancer. 64:2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khongkow M, Olmos Y, Gong C, Gomes AR,
Monteiro LJ, Yague E, Cavaco TB, Khongkow P, Man EP, Laohasinnarong
S, et al: SIRT6 modulates paclitaxel and epirubicin resistance and
survival in breast cancer. Carcinogenesis. 34:1476–1486. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen XM, Xie XB, Zhao Q, Wang F, Bai Y,
Yin JQ, Jiang H, Xie XL, Jia Q and Huang G: Ampelopsin induces
apoptosis by regulating multiple c-Myc/S-phase kinase-associated
protein 2/F-box and WD repeat-containing protein 7/histone
deacetylase 2 pathways in human lung adenocarcinoma cells. Mol Med
Rep. 11:105–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Y, Shu F, Liang X, Chang H, Shi L,
Peng X, Zhu J and Mi M: Ampelopsin induces cell growth inhibition
and apoptosis in breast cancer cells through ROS generation and
endoplasmic reticulum stress pathway. PLoS One. 9:e890212014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng HQ and Liu DY: Anti-invasive and
anti-metastatic effect of ampelopsin on melanoma. Ai Zheng.
22:363–367. 2003.(In Chinese). PubMed/NCBI
|
|
8
|
Qi S, Kou X, Lv J, Qi Z and Yan L:
Ampelopsin induces apoptosis in HepG2 human hepatoma cell line
through extrinsic and intrinsic pathways: Involvement of P38 and
ERK. Environ Toxicol Pharmacol. 40:847–854. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ni F, Gong Y, Li L, Abdolmaleky HM and
Zhou JR: Flavonoid ampelopsin inhibits the growth and metastasis of
prostate cancer in vitro and in mice. PLoS One. 7:e388022012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu T, Liu P, Ding F, Yu N, Li S, Wang S,
Zhang X, Sun X, Chen Y, Wang F, et al: Ampelopsin reduces the
migration and invasion of ovarian cancer cells via inhibition of
epithelial-to-mesenchymal transition. Oncol Rep. 33:861–867. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruan LP, Yu BY, Fu GM and Zhu DN:
Improving the solubility of ampelopsin by solid dispersions and
inclusion complexes. J Pharm Biomed Anal. 38:457–464. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang B, Dong S, Cen X, Wang X, Liu X,
Zhang H, Zhao X and Wu Y: Ampelopsin sodium exhibits antitumor
effects against bladder carcinoma in orthotopic xenograft models.
Anticancer Drugs. 23:590–596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin H: Study on preparation of
high-water-soluble ampelopsin sodium and its anti-tumor effects
(unpublished PhD thesis). Lanzhou University; 2006
|
|
14
|
Tada H, Shiho O, Kuroshima K, Koyama M and
Tsukamoto K: An improved colorimetic assay for interleukin 2. J
Immunol Methods. 93:157–165. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao SS and Zhen YS: Potentiation of
antimetabolite antitumor activity in vivo by dipyridamole and
amphotericin B. Cancer Chemother Pharmacol. 24:181–186. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fernandez V, Hartmann E, Ott G, Campo E
and Rosenwald A: Pathogenesis of mantle-cell lymphoma: All
oncogenic roads lead to dysregulation of cell cycle and DNA damage
response pathways. J Clin Oncol. 23:6364–6369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bisbis B, Delmas F, Joubès J, Sicard A,
Hernould M, Inzé D, Mouras A and Chevalier C: Cyclin-dependent
kinase (CDK) inhibitors regulate the CDK-cyclin complex activities
in endoreduplicating cells of developing tomato fruit. J Biol Chem.
281:7374–7383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ford HL and Pardee AB: Cancer and the cell
cycle. J Cell Biochem 32–33. (Suppl):166–172. 1999. View Article : Google Scholar
|
|
19
|
Nagasaka A, Kawane K, Yoshida H and Nagata
S: Apaf-1-independent programmed cell death in mouse development.
Cell Death Differ. 17:931–941. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burgess DJ: Apoptosis: Refined and lethal.
Nat Rev Cancer. 13:792013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Annamalai P, Thayman M, Rajan S, Raman LS,
Ramasubbu S and Perumal P: Ethyl acetate extract from marine sponge
Hyattella cribriformis exhibit potent anticancer activity by
promoting tubulin polymerization as evidenced mitotic arrest and
induction of apoptosis. Pharmacogn Mag. 11:345–355. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marko D, Kemény M, Bernady E, Habermeyer
M, Weyand U, Meiers S, Frank O and Hofmann T: Studies on the
inhibition of tumor cell growth and microtubule assembly by
3-hydroxy-4-[(E)-(2-furyl)methylidene]methyl-3-cyclopentene-1,2-dione,
an intensively coloured Maillard reaction product. Food Chem
Toxicol. 40:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tong C, Fan HY, Chen DY, Song XF, Schatten
H and Sun QY: Effects of MEK inhibitor U0126 on meiotic progression
in mouse oocytes: Microtuble organization, asymmetric division and
metaphase II arrest. Cell Res. 13:375–383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilson L and Jordan MA: Microtubule
dynamics-taking aim at a moving target. Chem Biol. 2:569–573. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maushagen R, Reers S, Pfannerstill AC,
Hahlbrock A, Stauber R, Rahmanzadeh R, Rades D, Pries R and
Wollenberg B: Effects of paclitaxel on permanent head and neck
squamous cell carcinoma cell lines and identification of
anti-apoptotic caspase 9b. J Cancer Res Clin Oncol. 142:1261–1271.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo Y, Ji X, Liu J, Li Z, Wang W, Chen W,
Wang J, Liu Q and Zhang X: Moderate intensity static magnetic
fields affect mitotic spindles and increase the antitumor efficacy
of 5-FU and taxol. Bioelectrochemistry. 109:31–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiu WH, Luo SJ, Chen CL, Cheng JH, Hsieh
CY, Wang CY, Huang WC, Su WC and Lin CF: Vinca alkaloids cause
aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA
damage, mitochondrial dysfunction, and apoptosis in lung
adenocarcinoma cells. Biochem Pharmacol. 83:1159–1171. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun B, Wingate H, Swisher SG, Keyomarsi K
and Hunt KK: Absence of pRb facilitates E2F1-induced apoptosis in
breast cancer cells. Cell Cycle. 9:1122–1130. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gamell C, Schofield AV, Suryadinata R,
Sarcevic B and Bernard O: LIMK2 mediates resistance to
chemotherapeutic drugs in neuroblastoma cells through regulation of
drug-induced cell cycle arrest. PLoS One. 8:e728502013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Tanaka M, Krstin S, Peixoto HS and
Wink M: The interference of selected cytotoxic alkaloids with the
cytoskeleton: An insight into their modes of action. Molecules.
21:E9062016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giannakakou P, Sackett D and Fojo T:
Tubulin/microtubules: Still a promising target for new
chemotherapeutic agents. J Natl Cancer Inst. 92:182–183. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Davis A, Jiang JD, Middleton KM, Wang Y,
Weisz I, Ling YH and Bekesi JG: Novel suicide ligands of tubulin
arrest cancer cells in S-phase. Neoplasia. 1:498–507. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Komlodi-Pasztor E, Sackett D, Wilkerson J
and Fojo T: Mitosis is not a key target of microtuble agents in
patient tumors. Nat Rev Clin Oncol. 8:244–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheriyamundath S, Mahaddalkar T, Kantevari
S and Lopus M: Induction of acetylation and bundling of cellular
microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest
in MDA-MB-231 cells. Biomed Pharmacotherapy. 86:74–80. 2017.
View Article : Google Scholar
|
|
35
|
Blaqosklonny MV, Ginanakakou P, el-Deiry
WS, Kingston DG, Higgs PI, Neckers L and Foji T: Raf-1/bcl-2
phosphorylatin: A step from microtuble damage to cell death. Cancer
Res. 57:130–135. 1997.PubMed/NCBI
|
|
36
|
Mahaddalkar T, Mehta S, Cheriyamundath S,
Muthurajan H and Lopus M: Tryptone-stabilized gold nanoparticles
target tubulin and inhibit cell viability by inducing an unusual
form of cell cycle arrest. Exp Cell Res. 360:163–170. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Y, Sun X, LaMont JT, Pardee AB and Li
CJ: Selective killing of cancer cells by β-lapachone: Direct
checkpoint activation as a strategy against cancer. PNAS.
100:2674–2678. 2003. View Article : Google Scholar : PubMed/NCBI
|
